Halo Neuroscience raises $13M to further develop and commercialize neuromodulation headset aimed at inducing “hyperplasticity”

___

Halo Neu­ro­science rais­es $13m in Series B (Mass Device):

“Neu­rostim­u­la­tion device mak­er Halo Neu­ro­science said today it raised $13 mil­lion in a Series B round of financ­ing to sup­port its Halo Sport neu­rostim head­set designed to improve mus­cle mem­o­ry acqui­si­tion from ath­let­ic training.

The fund­ing round was led by TPG and joined by exist­ing investors Lux Cap­i­tal, JAZZ Ven­ture Part­ners and XFund, the San Fran­cis­co-based com­pa­ny said…

The company’s flag­ship device, the Halo Sport, is designed to deliv­er neu­rostim­u­la­tion to the motor cor­tex in a 20 minute neu­ro­prim­ing ses­sion which Halo Neu­ro­science claims induces a tem­po­rary state of hyper­plas­tic­i­ty that allows neur­al path­ways from the motor cor­tex to the mus­cles to be opti­mized and strengthened.”

News in Context:

• Impor­tant insights on the grow­ing home use of tDCS brain stim­u­la­tion: old­er-than-expect­ed users, pos­i­tive self-report­ed results for treat­ment of depres­sion but neg­a­tive for self-enhance­ment, and a cou­ple areas of con­cern (severe burns, frequency)
• Study: Tran­scra­nial Direct Cur­rent Stim­u­la­tion (tDCS) can reduce fatigue in patients with Mul­ti­ple Scle­ro­sis (MS)
• Next: How to nav­i­gate tran­scra­nial elec­tri­cal stim­u­la­tion claims and devices
• Pre­sen­ta­tion by Anna Wexler and oth­ers at the 2017 Sharp­Brains Vir­tu­al Sum­mit: